Ilyinskaya Hospital, Krasnogorsk, Russia.
Khirurgiia (Mosk). 2023(10):20-28. doi: 10.17116/hirurgia202310120.
To demonstrate safe introduction of a new technology (Da Vinci robotic system) into laparoscopic bariatric practice.
We analyzed treatment outcomes in patients with morbid obesity who underwent robot-assisted sleeve gastrectomy between 2020 and 2023. The same team of surgeons performed all operations. Evolution of technique and preparation of the operating theatre were recorded. Demographic data of patients, surgery time (docking and total surgery time), simultaneity of intervention, intraoperative and postoperative complications, as well as weight loss after 6 months were retrospectively analyzed.
There were 15 robot-assisted sleeve gastrectomies between 2020 and 2023. Of these, 14 patients underwent surgery without complications. One patient was diagnosed with portal vein thrombosis that required anticoagulation. Median surgery time 194 [173.5; 241] min, period between incision and docking - 35 [30; 36] min. The length of hospital-stay was 3 days. The median weight loss after 6 months was 37.5% [29.5; 51.2].
This study demonstrates safe introduction of a new technology to prepare the bariatric team for more complex surgical interventions in the future.
展示将新技术(达芬奇机器人系统)安全引入腹腔镜减重手术实践。
我们分析了 2020 年至 2023 年间接受机器人辅助袖状胃切除术的病态肥胖患者的治疗结果。同一组外科医生完成了所有手术。记录了技术的演变和手术室的准备情况。回顾性分析了患者的人口统计学数据、手术时间(对接和总手术时间)、干预的同时性、术中及术后并发症以及 6 个月后的体重减轻情况。
2020 年至 2023 年间共进行了 15 例机器人辅助袖状胃切除术。其中 14 例患者手术无并发症。1 例患者诊断为门静脉血栓形成,需抗凝治疗。中位手术时间 194 [173.5;241] 分钟,切口与对接时间间隔 35 [30;36] 分钟。住院时间为 3 天。6 个月后的中位体重减轻率为 37.5% [29.5;51.2]。
本研究证明了新技术的安全引入,为未来更复杂的手术干预做好了减重团队的准备。